Introduction
Combined UVA irradiation/riboflavin treatment represents a new method, which increases the biomechanical rigidity of the cornea by collagen cross-linking [1] . In clinical trials, the progression of keratoconus could be stopped [2] [3] [4] . Possible cytotoxic effects of this procedure on the corneal endothelium have been investigated in in vitro studies and in rabbits [5, 6] . In keratoplasty, transplant rejection may also be caused by the cells in the donor cornea [7] . The cells are antigen-presenting cells but also keratocytes which are the carriers of immune complexes [8] . Therefore we sought to address in a mouse model the fact that, following collagen cross-linking during UVA/riboflavin irradiation, the stromal cells and especially the antigen-presenting cells might both be removed, which would result in an abolished or at least diminished immunological reaction after keratoplasty. It is thereby important to ensure survival of the nonproliferating or postmitotic corneal endothelial cell layer. 
Material and Methods

Wang
In vitro UV Irradiation
Enucleated mouse eyes were irradiated with UVA 370 nm using a single UVA diode (Roithner Lasertechnik, Vienna, Austria) at a distance of 1 cm from the cornea. The UVA diode was covered with a Cliplite (Conrad Electronics) to get a restricted irradiation area of 2 mm diameter on the center of the cornea. For abrasion of the corneal epithelium, riboflavin photosensitizer solution containing riboflavin-5-phosphate and dextran T-500 was applied onto the cornea 5 min before the irradiation and every 5 min during the 30-min irradiation process ( fig. 1 a) . Different irradiation parameters, involving 0.1-0.5% riboflavin, 0-20% dextran and irradiation energy of 0.5-4 mW/cm 2 , with an irradiation time of 15-30 min, were regulated in order to get an optimal irradiation condition. The mouse eyes were cultivated in culture medium II (Gibco Invitrogen), consisting of 2.2 g/l H 2 CO 3 , L -glutamine, 12.5 m M HEPES, penicillin-streptomycin 50 IU/ml and dextran T-500 (Biochirom AG, Germany), incubated at 37 ° C for 1, 2 or 3 days, respectively.
Histological Studies
Mouse eyes were fixed in 4% formalin and prepared for paraffin sectioning. The sections were stained with hematoxylin-eosin. Serial sections were immunohistochemically stained using the avidin-biotin-peroxidase complex procedure (Vector Laboratories, Burlingame, Calif., USA) to determine the presence of caspase 3. Briefly, deparaffinized sections were boiled in 10 m M sodium citrate buffer at pH 6.0 for 10 min and incubated with diluted blocking solution (1: 100) for 1 h. All sections were incubated with diluted primary antibody of anti-rabbit caspase 3 (1: 200, Cell Signaling) overnight at 4 ° C, with biotinylated secondary goat anti-rabbit antibody (1: 100, Vector Laboratories) for 30 min at room temperature, and with avidin-peroxidase conjugate for 30 min. Sections were developed in 0.05% diaminobenzidine solution and counterstained with hematoxylin. Negative control incubation was omitted with the primary antibody. All sections were viewed with a Zeiss Axiophot photomicroscope (Germany).
Western Blot Analysis for Cleaved Caspase 3
Lysates of corneal tissues were prepared by mechanically dissecting intact corneas with a blade and homogenized in lysis buffer (20 m M Tris, pH 7.5, 150 m M NaCl, 1% Triton X-100, protease cocktail inhibitor, 0.1 g leupeptin, 2 g/ml aprotinin); homogenates were centrifuged for 10 min, at 10,000 g . Samples were loaded onto 12% gel and separated by electrophoresis. The proteins were transferred to polyvinyl difluoride membranes (Millipore Corp., USA) by electrophoresis in transfer buffer. Membranes were blocked in blocking buffer of 5% nonfat dry milk in 0.3% Tween-20 PBS solution, then incubated in anti-rabbit caspase 3 of 1: 100 (Cell Signaling) with blocking buffer overnight at 4 ° C. Following incubation in horseradish-peroxidaseconjugated goat anti-rabbit IgG (Jackson Immunoresearch Laboratories) in blocking buffer for 30 min, horseradish peroxidase labeling was determined by enhanced chemiluminescence (Amersham Biosciences, UK), and the membrane was exposed to X-ray film (Amersham Biosciences). In vitro cultured human retinal pigment epithelial cells that had been treated with staurosporine (1 g/ml) overnight were used as positive control for cleaved caspase 3; nontreated normal cornea tissue was regarded as negative control.
Results
In vitro UVA Irradiation
Concerning the in vitro model, the optimal cultivation conditions were: 0.5% riboflavin, 10% dextran, irradiation time set to 30 min; following the variable cultivation time from 1 to 3 days, the cell nucleus or nuclear fragment numbers in corneal stroma were reduced. Immunohistochemical staining of caspase-3-positive cells was increased in the stroma from posttreatment day 1 to day 2 on the center and periphery of the cornea. Extensive caspase 3 positive staining was displayed on day 2 after UVA irradiation ( fig. 1 e) . Until day 3, with the irradiation dose of 1.2 mW/cm 2 , almost all of the corneal component cells in the stroma underwent apoptosis, and an absolutely cell-free zone was achieved from the peripheral to the central cornea, except for the endothelium preserved on Descemet's membrane in extenso. However, epithelial cells were still absent in the center of the mouse cornea ( fig. 1 c) . In contrast, when the irradiation doses were increased above 1.2 mW/cm 2 , including the keratocytes in the stroma, even the corneal endothelial cells were destroyed and only corneal collagen remained.
Expression of Cleaved Caspase 3 in Irradiated Corneas
To prove the immunohistological results, UVA-irradiated mouse corneas incubated for 1 or 2 days and normal nontreated corneas were subjected to SDS-PAGE and Western blotting for cleaved caspase 3 expression. A polyclonal antibody that identifies both 17-and 19-kDa subunits of mouse cleaved caspase 3 and human cleaved caspase 3 was used. A faint band of 17 kDa was found on posttreatment day 1. Another strong band of both 17 and 19 kDa was detected on posttreatment day 2. There was no signal showing on nontreated normal mouse corneas. The apoptotic process developed after UVA irradiation on day 1, then amounts of apoptotic nuclear cells increased on posttreatment day 2. The results confirmed the immunohistochemical assay findings that UVA-irradiated corneas contain apoptotic cells ( fig. 1 f) . 
Discussion
To improve high-risk corneal grafting, research is accomplished to find new therapies, which are more efficient than that used universally. A new and possibly additional concept is to manipulate the antigen-presenting cells in the cornea in order to modulate the immunological state of the transplant [9] [10] [11] [12] . Antigen-presenting cells reside in the deeper stromal layers. Numerous dendritic cells reside especially in the anterior stroma [13] .
Hence we suggested to utilize a physical method in which the cells could be reduced or completely removed, and immunological cells were locally destroyed, also by mechanical abrasion of corneal epithelial cells, with enrichment of antigen-presenting cells. In the present study, a well-established mouse model of UVA irradiation combined with riboflavin was used to induce apoptosis in the corneal stroma in vitro. The process is similar to the human donor cornea cultivation system. The cytotoxic irradiance threshold of 1.2 mW/cm 2 for keratocytes could be confirmed in the cultivated mouse cornea. Based on the Lambert-Beer law, the safe threshold for corresponding UVA irradiation on the cultivated human cornea could also be deduced. In the case of corneal epithelial debridement wounds, the keratocytes beneath the basement membrane undergo apoptosis immediately. Shortly after death, the cells are replaced by new keratocytes by mitosis of adjacent cells, and consequently no further keratocyte response occurs. Approximately 6 h after injury, the activated keratocytes enter into the cell cycle and subsequently migrate to the site of injury [14] . If the UVA-irradiated corneas are transplanted as donor, based on the above theory, the keratocytes of the recipient could be regenerated from the recipient's edge of the wound bed to the graft. Also the scraped epithelium could be replaced by recipient corneal epithelial cells. Then the donor graft is not recognized as foreign body any more. In principle, the risk of corneal transplant rejection could be reduced or prevented.
In conclusion, UVA/riboflavin treatment significantly promotes apoptosis of mouse corneal stromal cells. The discovery provides the possibility to prevent or reduce immunological reactions and the risk of graft rejection by pretreatment. It supports the further application of this new method in clinical corneal transplantation. Nowadays, an animal model of keratoplasty for preclinical study is under way; many more results need to be investigated.
